Press "Enter" to skip to content

Ibrutinib Combo in Chronic Lymphocytic Leukemia is Superior, but Costly – Cancer Network

admin 0

Ibrutinib Combo in Chronic Lymphocytic Leukemia is Superior, but Costly  Cancer Network

While ibrutinib plus rituximab may improve progression-free survival in chronic lymphocytic leukemia, it is a costly option for some patients.

“lymphoma cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *